Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Market Analysis & Valuation

UpdatedJun 25, 2026
DataAggregated Company Financials
Companies204
  • 7D1.8%
  • 3M10.3%
  • 1Y17.0%
  • YTD6.1%

The market is up 1.8% over the last week, with the Healthcare sector leading the way, up 2.6%. As for the past 12 months, the market is up 17%. As for the next few years, earnings are expected to grow by 11% per annum.

Market Valuation and Performance

Has the Swiss Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 25 Jun 2026CHF 2.1tCHF 782.2bCHF 105.0b20.6x19.9x2.7x
Sat, 23 May 2026CHF 2.0tCHF 772.8bCHF 103.7b20.7x19.4x2.6x
Mon, 20 Apr 2026CHF 2.0tCHF 777.6bCHF 109.3b21.2x18.5x2.6x
Wed, 18 Mar 2026CHF 1.9tCHF 777.8bCHF 109.1b20x17.7x2.5x
Fri, 13 Feb 2026CHF 2.0tCHF 787.8bCHF 117.5b20.5x17.2x2.6x
Sun, 11 Jan 2026CHF 2.0tCHF 799.5bCHF 115.2b20.5x17.6x2.5x
Tue, 09 Dec 2025CHF 1.9tCHF 802.2bCHF 114.9b19.3x16.9x2.4x
Thu, 06 Nov 2025CHF 1.9tCHF 802.5bCHF 114.6b19.2x16.3x2.3x
Sat, 04 Oct 2025CHF 1.9tCHF 774.1bCHF 90.3b19.6x20.9x2.4x
Mon, 01 Sep 2025CHF 1.9tCHF 775.5bCHF 90.1b19.9x20.6x2.4x
Wed, 30 Jul 2025CHF 1.8tCHF 795.3bCHF 108.6b20.6x16.9x2.3x
Fri, 27 Jun 2025CHF 1.8tCHF 785.8bCHF 106.8b20.1x16.7x2.3x
Sun, 25 May 2025CHF 1.8tCHF 785.0bCHF 106.4b20.1x17.1x2.3x
Tue, 22 Apr 2025CHF 1.7tCHF 832.4bCHF 156.8b18.6x10.9x2.1x
Thu, 20 Mar 2025CHF 1.9tCHF 849.3bCHF 158.6b20x12.1x2.3x
Sat, 15 Feb 2025CHF 1.9tCHF 820.2bCHF 116.4b22.2x16.4x2.3x
Mon, 13 Jan 2025CHF 1.8tCHF 820.2bCHF 118.0b20.8x15x2.2x
Wed, 11 Dec 2024CHF 1.7tCHF 809.4bCHF 117.0b20.7x14.9x2.2x
Fri, 08 Nov 2024CHF 1.8tCHF 812.1bCHF 117.5b20.2x15.1x2.2x
Sun, 06 Oct 2024CHF 1.8tCHF 804.5bCHF 114.1b21.3x15.8x2.2x
Tue, 03 Sep 2024CHF 1.9tCHF 801.8bCHF 113.8b21.8x16.3x2.3x
Thu, 01 Aug 2024CHF 1.8tCHF 793.4bCHF 125.6b21.9x14.7x2.3x
Sat, 29 Jun 2024CHF 1.8tCHF 801.3bCHF 125.7b21.1x14.3x2.2x
Mon, 27 May 2024CHF 1.8tCHF 808.4bCHF 126.7b21.7x14.2x2.2x
Wed, 24 Apr 2024CHF 1.7tCHF 770.5bCHF 97.2b21.5x17.9x2.3x
Fri, 22 Mar 2024CHF 1.8tCHF 766.7bCHF 98.2b21.3x18.1x2.3x
Sun, 18 Feb 2024CHF 1.7tCHF 769.0bCHF 109.6b19.6x15.7x2.2x
Tue, 16 Jan 2024CHF 1.7tCHF 762.8bCHF 109.7b18.2x15.3x2.2x
Thu, 14 Dec 2023CHF 1.7tCHF 768.6bCHF 110.8b18.6x15.2x2.2x
Sat, 11 Nov 2023CHF 1.6tCHF 776.2bCHF 112.2b17.5x14.2x2.1x
Mon, 09 Oct 2023CHF 1.6tCHF 764.2bCHF 100.7b18.1x16.2x2.1x
Wed, 06 Sep 2023CHF 1.7tCHF 748.3bCHF 98.9b18.8x16.8x2.2x
Fri, 04 Aug 2023CHF 1.7tCHF 741.8bCHF 76.3b18.3x22x2.3x
Sun, 02 Jul 2023CHF 1.7tCHF 757.2bCHF 76.9b19.5x22.4x2.3x
Price to Earnings Ratio

22.4x


Total Market Cap: CHF 1.7tTotal Earnings: CHF 76.9bTotal Revenue: CHF 757.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Market Price to Earnings3Y Average 16.8x202420252026
Current Market PE
  • Investors are optimistic on the Swiss market, and appear confident in strong long term growth rates.
  • The market is trading at a PE ratio of 19.9x which is higher than its 3-year average PE of 16.8x.
Past Earnings Growth
  • The earnings for Swiss listed companies have grown 11% per year over the last three years, while revenues have remained steady.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Sector Trends

Which sectors have driven the changes within the Swiss Market?

CH Market1.84%
Consumer Staples4.92%
Healthcare2.65%
Consumer Discretionary1.55%
Telecom1.16%
Materials0.85%
Industrials0.70%
Financials0.66%
Real Estate0.11%
Utilities-1.38%
Tech-1.47%
Sector PE
  • Investors favour the Tech sector the most for future growth, which is trading above its 3-year average PE ratio of 27.8x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 21.3% which is higher than its past year's earnings decline of 14.4% per year.
  • The Financials sector is the least preferred by investors for future growth. Although, investor sentiment seems to have improved given that it's trading above its 3-year average of 7.1x.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 21% over the next 5 years.
  • This is better than its past earnings decline of 14% per year.
  • In contrast, the Real Estate sector is expected to see its earnings decline by 7.0% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
NESN NestléCHF 82.894.8%
+CHF 9.8b		4.0%PE23.6xConsumer Staples
NOVN NovartisCHF 124.342.8%
+CHF 6.1b		30.9%PE20.7xHealthcare
ROP Roche HoldingCHF 332.001.3%
+CHF 3.3b		28.0%PE20.5xHealthcare
GALD Galderma GroupCHF 183.556.2%
+CHF 2.5b		62.1%PE86.4xHealthcare
LONN Lonza GroupCHF 528.407.1%
+CHF 2.5b		-6.6%PE40.6xHealthcare
See more

Market Insights

Header cover image
Every trend sets off ripples. The further out you think, the less crowded it gets.
Continue reading
The gravity of the SpaceX IPO

Latest News

LONN
CHF 528.40
Lonza Group
7D
7.1%
1Y
-6.6%
CFR
CHF 185.50
Compagnie Financière Richemont
7D
2.0%
1Y
24.5%
Analysis Article • 6h

Is Now The Time To Look At Buying Compagnie Financière Richemont SA (VTX:CFR)?

Compagnie Financière Richemont SA ( VTX:CFR ) led the SWX gainers with a relatively large price hike in the past couple...
HOLN
CHF 74.64
Holcim
7D
-3.7%
1Y
27.5%
Narrative Update • Jun 24

HOLN: Rich P/E Will Likely Cap Upside Despite Recent Upgrades

Holcim's updated fair value estimate has increased to CHF 63.67, supported by a series of analyst actions, including a slightly lower CHF 73 target at RBC Capital, multiple upgrades to Outperform or Buy with higher price targets such as CHF 92, and updated assumptions for steadier revenue growth, a firmer profit margin, a lower discount rate, and a slightly reduced future P/E. Analyst Commentary Recent research on Holcim reflects a mix of optimism and caution, with several firms adjusting ratings and price targets as they reassess the company’s earnings profile, valuation, and execution risks.
VACN
CHF 665.60
VAT Group
7D
-2.7%
1Y
98.7%
Narrative Update • Jun 23

VACN: Higher Cycle Hopes Will Confront Rich Multiple And Execution Risks

The updated fair value for VAT Group has been increased to CHF 617 from CHF 603. This reflects analysts' higher price targets in recent research, based on their rationale around slightly stronger revenue growth, profit margins, and a marginally lower discount rate.
ROP
CHF 332.00
Roche Holding
7D
1.3%
1Y
28.0%
NESN
CHF 82.89
Nestlé
7D
4.8%
1Y
4.0%
NOVN
CHF 124.34
Novartis
7D
2.8%
1Y
30.9%
SOON
CHF 193.90
Sonova Holding
7D
-2.0%
1Y
-19.4%
Narrative Update • Jun 22

SOON: Execution Gains And Portfolio Shift Will Support Medium Term Re-Rating

Analysts have trimmed their fair value estimate for Sonova Holding only slightly to about CHF 290. This reflects a mix of higher and lower Street price targets and updated assumptions on revenue growth, profitability and future P/E expectations that have been incorporated into the new price target.
ABBN
CHF 86.58
ABB
7D
1.4%
1Y
88.8%
Narrative Update • Jun 22

ABBN: Automation And Electrification Projects Will Support Measured Long Term Upside

ABB's updated analyst price target implies a move of roughly CHF 5 higher, with analysts pointing to refined fair value estimates, a slightly adjusted discount rate, and modest tweaks to revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Recent research on ABB shows a cluster of bullish analysts lifting price targets and, in some cases, upgrading their views.
LOGN
CHF 83.94
Logitech International
7D
-2.2%
1Y
18.2%
BEAN
CHF 928.00
BELIMO Holding
7D
-3.4%
1Y
16.3%
Analysis Article • Jun 19

BELIMO Holding (SWX:BEAN) Stock Could Be 10% Overvalued After Morgan Stanley Upgrade

Belimo Holding (SWX:BEAN) moved sharply higher after Morgan Stanley upgraded the stock, citing robust anticipated growth in the company’s data center cooling operations linked to expanding AI infrastructure demand. See our latest analysis for BELIMO Holding. At a share price of CHF965.5, BELIMO Holding has seen strong recent momentum, with a 30 day share price return of 27.54% and a 90 day return of 54.85%. The 1 year total shareholder return of 23.37% and 5 year total shareholder return of...
HUBN
CHF 233.00
Huber+Suhner
7D
-7.2%
1Y
168.1%
Narrative Update • Jun 18

HUBN: Optical Partnerships And Higher Margins Will Drive Strong Share Upside

Analysts have lifted their price target for Huber+Suhner from CHF 189 to CHF 320, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E as key drivers of the change. What’s in the News for Huber+Suhner Huber+Suhner is working with Microsoft’s Azure team in Romsey, UK, to develop and manufacture hollow core fiber (HCF) cable and connector solutions that are already deployed in the Azure network, with higher capacity variants under development.
PGHN
CHF 649.00
Partners Group Holding
7D
-9.1%
1Y
-35.2%
Narrative Update • Jun 18

PGHN: Future Returns Will Hinge On Managing Fund Liquidity And Execution Risks

The analyst price target for Partners Group Holding has been reduced from CHF 930 to CHF 760. This reflects updated views based on more moderate revenue growth assumptions, a slightly higher discount rate and a lower future P/E, partially offset by higher expected profit margins.
GALD
CHF 183.55
Galderma Group
7D
6.2%
1Y
62.1%
Narrative Update • Jun 17

GALD: Rising Execution Bar And Rich P/E Will Likely Cap Future Share Upside

Analysts have raised the Galderma Group price target by CHF 5 to CHF 125.65, citing updated assumptions on fair value, revenue growth, profit margins and forward P/E that are consistent with a recent series of target increases from major banks. Analyst Commentary Recent Street research on Galderma Group points to a cluster of higher price targets, framed around updated assumptions for earnings quality, revenue mix and P/E levels.
GIVN
CHF 3,423.00
Givaudan
7D
7.8%
1Y
-12.5%
Narrative Update • Jun 09

GIVN: Pricing Power And Eurofragance Deal Will Support Future Margin Resilience

The analyst price target for Givaudan has been adjusted slightly to CHF 3,415 from CHF 3,447. This reflects a blend of cautious tweaks to growth and discount rate assumptions.
UHR
CHF 202.90
Swatch Group
7D
-3.4%
1Y
56.4%